Rosetta Genomics Picks Up Pacific Rim Distributor | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies will distribute Rosetta Genomics' cancer diagnostic tests in Australia, New Zealand, and Singapore, under an exclusive agreement announced by Rosetta Genomics today.

GTG, a Melbourne-based genetic testing lab, will market the company's microRNA-based miRview tests in the three countries, Rosetta Genomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.